Exhibiting at VIV Asia 2025

China Chemical & Pharmaceutical Co., Ltd. (CCPC)

China Chemical & Pharmaceutical Co., Ltd. (CCPC) is a leading pharmaceutical manufacturer specializing in Active Pharmaceutical Ingredients (APIs), finished dosage forms, over-the-counter (OTC) products, and animal health solutions. Established in 1952 and headquartered in Taipei, Taiwan, CCPC has built a reputation for high-quality pharmaceutical production, stringent regulatory compliance, and global market leadership.

With over 70 years of expertise in drug manufacturing and pharmaceutical innovation, CCPC continues to expand its presence across Asia, North America, Europe, and other key international markets.

Core Business and Specialization

CCPC is a fully integrated pharmaceutical company, offering research-driven drug formulations, API synthesis, and finished dosage production to serve global healthcare, veterinary, and nutraceutical industries.

Key Specializations:

• Active Pharmaceutical Ingredients (APIs) – High-purity antibiotics, cardiovascular drugs, and gastrointestinal medicines.
• Finished Dosage Forms – Production of tablets, capsules, and injectable drugs.
• Over-the-Counter (OTC) Products – Consumer-friendly medicines including pain relievers and cold remedies.
• Animal Health Solutions – Veterinary pharmaceuticals and feed additives for livestock and pets.

Product Portfolio

Active Pharmaceutical Ingredients (APIs)

• Antibiotics – Cephalosporins, penicillins, and macrolides.
• Cardiovascular Drugs – Beta-blockers, ACE inhibitors, and statins.
• Gastrointestinal Drugs – Proton pump inhibitors (PPIs) and H2 receptor antagonists.

Finished Dosage Forms

• Tablets – Solid oral dosage forms for chronic and acute disease treatments.
• Capsules – Encapsulated drug formulations for enhanced bioavailability.
• Injectables – Sterile injectable pharmaceuticals for hospital and clinical use.

Over-the-Counter (OTC) Products

• Pain Relievers – Ibuprofen, acetaminophen (paracetamol).
• Cold and Flu Remedies – Decongestants, antihistamines, and cough syrups.
• Nutritional Supplements – Vitamins, minerals, and herbal formulations.

Animal Health Solutions

• Veterinary Pharmaceuticals – Antibiotics and anti-inflammatory drugs for livestock and companion animals.
• Feed Additives – Nutritional and therapeutic supplements for enhancing animal health and productivity.

Research & Development

CCPC invests over 8% of its annual revenue in R&D, focusing on formulation development, drug stability, and API synthesis improvements. The company operates state-of-the-art research laboratories with collaborations across universities, biotech firms, and global healthcare organizations.

Key R&D Focus Areas

• Biopharmaceutical Innovations – Developing next-generation biosimilars and biologics.
• Sustainable API Production – Implementing green chemistry techniques.
• Controlled Release Drug Formulations – Enhancing drug efficacy and patient compliance.

Global Market Presence

CCPC has established a robust global distribution network, supplying pharmaceutical products to over 60 countries, including Asia-Pacific, Europe, North America, and Latin America.

Key Export Markets

• Asia-Pacific: Taiwan, China, Japan, South Korea, India.
• Europe: Germany, UK, France, Netherlands, Spain.
• North America: United States, Canada, Mexico.
• South America: Brazil, Argentina, Chile.

Certifications & Compliance

CCPC adheres to strict international regulatory and safety standards, ensuring its products meet global pharmaceutical requirements.

Industry Certifications

• ISO 9001:2015 – Quality Management System Certification.
• EU-GMP Certified – Compliance with European Good Manufacturing Practices.
• US FDA Approved – Authorized for pharmaceutical sales in the United States.
• PIC/S GMP Certified – Ensuring global manufacturing standards.

Shipment and Export Capabilities

CCPC operates a highly efficient logistics network, ensuring timely deliveries of pharmaceutical products worldwide.

• Annual API Production Capacity: Over 5,000 metric tons.
• Primary Shipping Ports: Taipei, Shanghai, Hong Kong.
• Global Distribution Channels: Direct partnerships with pharmaceutical companies, hospitals, and distributors.

Customer Testimonials

CCPC has received positive industry recognition from healthcare providers, pharmaceutical distributors, and regulatory bodies worldwide.

"CCPC’s high-purity APIs have helped us enhance our generic drug formulations, ensuring superior drug stability and efficacy."
– Pharmaceutical Manufacturer, Germany

"Their OTC pain relievers and cold medications are among the best-selling brands in our retail pharmacy chain."
– Pharmacy Chain Operator, Taiwan

Major Achievements

• Top 5 Pharmaceutical Manufacturers in Taiwan.
• Over 70 years of pharmaceutical excellence and innovation.
• Expansion into over 60 global markets.
• Annual R&D investment exceeding 8% of company revenue.

Future Outlook

As global demand for high-quality pharmaceuticals continues to rise, CCPC remains committed to drug innovation, international expansion, and advanced healthcare solutions, ensuring affordable, effective, and accessible medicines for global healthcare needs.